Treatment of Inflammatory Diseases Selective Inhibitor of JAK1, for the Preclinical Characterization of GLPG0634, a

Feyen and Christel MenetFletcher, Reginald Brys, Gerben van 't Klooster, Jean H. M.Vandeghinste, Beatrice Vayssiere, Steve De Vos, Stephen Lepescheux, Thierry Christophe, Katja Conrath, NickPhilippe Clement-Lacroix, Luc Nelles, Bart Smets, Lien Luc Van Rompaey, Rene Galien, Ellen M. van der Aar,ol.1201348http://www.jimmunol.org/content/early/2013/09/04/jimmunJ Immunol€ published online 4 September 2013MaterialSupplementary8.DC1.htmlhttp://www.jimmunol.org/content/suppl/2013/09/04/jimmunol.120134Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at: